(Total Views: 566)
Posted On: 01/04/2021 2:31:37 PM
Post# of 153916
Here is a recent publication on cytokine storms which references Dr. BP's paper and the eIND results but failed to mention leronlimab by name.
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
"Therapies against the chemokine receptor CCR5 have been administered for compassionate use in critically ill patients. After administration, observations included receptor occupancy on T cell and macrophages and reductions in IL‐6 levels, SARS–CoV‐2 viremia, and CD4:CD8 ratios (85)."
85. Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari JP, et al. Disruption of the CCL5/RANTES‐CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID‐19. medRxiv 2020:2020.05.02.20084673.
https://onlinelibrary.wiley.com/doi/full/10.1...learlyview
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
"Therapies against the chemokine receptor CCR5 have been administered for compassionate use in critically ill patients. After administration, observations included receptor occupancy on T cell and macrophages and reductions in IL‐6 levels, SARS–CoV‐2 viremia, and CD4:CD8 ratios (85)."
85. Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari JP, et al. Disruption of the CCL5/RANTES‐CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID‐19. medRxiv 2020:2020.05.02.20084673.
https://onlinelibrary.wiley.com/doi/full/10.1...learlyview
(4)
(0)
